Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats
- 24 April 1995
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 678 (1-2), 168-176
- https://doi.org/10.1016/0006-8993(95)00181-o
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in ratsBrain Research, 1993
- Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in ratsBrain Research, 1992
- Ingestive behavior following central [D-Ala2, Leu5, Cys6]-Enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptorPharmacology Biochemistry and Behavior, 1991
- Mediation of insulin hyperphagia by specific central opiate receptor antagonistsBrain Research, 1991
- Reduction by central ß-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditionsBrain Research, 1990
- Suppression of nocturnal, palatable and glucoprivic intake in rats by the κ opioid antagonist, nor-binaltorphamineBrain Research, 1990
- Norbinaltorphimine: Antagonist profile at κ opioid receptorsEuropean Journal of Pharmacology, 1987
- Stress and sucrose hyperphagia: Role of endogenous opiatesPharmacology Biochemistry and Behavior, 1984
- Naltrexone suppresses hyperphagia induced in the rat by a highly palatable dietPharmacology Biochemistry and Behavior, 1981
- Suppression of food intake and body weight gain by naloxone in ratsLife Sciences, 1979